BUSINESS SEGMENT INFORMATION

6 Months Ended

Jun. 30, 2012

Segment Reporting [Abstract]

Business Segment Information [Text Block]

Note 2. BUSINESS SEGMENT INFORMATION

BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and a global supply chain organization are utilized and responsible for the development and delivery of products to the market. Products are distributed and sold through regional organizations that serve the United States; Europe; Latin America, Middle East and Africa; Japan, Asia Pacific and Canada; and Emerging Markets defined as Brazil, Russia, India, China and Turkey. The business is also supported by global corporate staff functions. Segment information is consistent with the financial information regularly reviewed by the chief operating decision maker, the chief executive officer, for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods.

Net sales of key products were as follows:

		Three Months Ended June 30,				Six Months Ended June 30,
Dollars in Millions		2012		2011		2012		2011
Plavix* (clopidogrel bisulfate)		$	741	$	1,865	$	2,434	$	3,627
Avapro*/Avalide* (irbesartan/irbesartan-hydrochlorothiazide)			117		251		324		541
Eliquis (apixaban)			1		-		1		-
Abilify* (aripiprazole)			711		706		1,332		1,330
Reyataz (atazanavir sulfate)			406		396		764		762
Sustiva (efavirenz) Franchise			388		371		774		714
Baraclude (entecavir)			357		292		682		567
Erbitux* (cetuximab)			179		173		358		338
Sprycel (dasatinib)			244		193		475		365
Yervoy (ipilimumab)			162		95		316		95
Orencia (abatacept)			290		228		544		427
Nulojix (belatacept)			3		2		4		2
Onglyza/Kombiglyze (saxagliptin/saxagliptin and metformin)			172		112		333		193
Mature Products and All Other			672		750		1,353		1,484
	Net Sales	$	4,443	$	5,434	$	9,694	$	10,445